Euradiomics

The Euradiomicsproject is financially funded by the Interreg EMR program. The total budget for the project is € 2.968.622,07 and Interreg contribution is € 1.456.340,11.

Interreg Euregio-Maas-Rhine is one of the 60 Interreg areas in Europe where European Union funds are made available for cross-border collaboration. Its area covers parts of Belgium, Germany and The Netherland.

Medical imaging has become the cornerstone of modern medicine, however many diseases cannot be detected by the human eye or properly assessed. Given the shortcomings in manual and semi-quantitative methods, it was necessary to develop an approach known as "Radiomics". Radiomics is a breakthrough technology based on a unique image software to extract and obtain very large amounts of quantitative image features from standard medical images and translate them into radiomics signatures. Moreover, it is a method based on the principle of "Federated learning", which respects the privacy laws concerning patient information. With this technology we can now share Radiomics knowledge with the world whilst being in full compliance with legislation on the protection of privacy. This technology enables the analysis of millions of medical images without the data physically leaving the hospital/clinic/institute, thereby resolving possible privacy protection issue. The goal of this project is to continually provide sustainable marketing and product development for radiomics and that the analysis of medical image will be applied in the clinic as a standard of care. Additionally, radiomics signatures will be integrated into multifactorial decision support for both physicians and patients resulting in better care at lower costs.

The Euradiomics projects is led by Radiomics and includes the following partners:

• University of Maastricht
• CHU Liege 
• Dosevue 
• RWTH Aachen
• Limburg Oncologisch Centrum
• Health innovation ventures 

The project has its own project-webpage: www.euradiomics.com where more information on the project can be found.